Senior Biomarker Biostatistician — AI/ML Focus (Europe)

Syneos Health, Inc.; España; Vor Ort; EUR 80.000 - 110.000; Vollzeit

Zusammenfassung

Syneos Health, Inc. is seeking a Principal Biostatistician - Biomarker to lead biomarker statistics across European studies. The role focuses on RNA/genomics data, AI/ML integration, and advanced analytics with production-level code in Python/R.

Strong collaboration with cross-functional teams is required and independence is essential. You will contribute to Biomarker Evaluation Plans, reports, and interpretation of statistical deliverables within a pharma context, spanning diverse therapeutic

Qualifikationen

• PhD or MSc in Biostatistics, Statistics or Mathematics.
• Experience with ML and biomarker data is required.
• Knowledge of RNA and genomic data handling is a plus.

Aufgaben

• Collaborates with other functions to plan, execute and analyze biomarker aspects of studies.
• Develops the Biomarker Evaluation Plan for studies.
• Provides statistical input in clinical development discussions, including AI/ML approaches.
• Coordinates statistical activities for biomarker R&D.
• Conducts advanced data analysis for genomics and biomarker stats, including programming.
• Handles RNA, olink and other biomarker data.
• Produces Biomarker Evaluation Report with deliverables interpretation.
• Works independently on routine and complex statistical questions.
• Develops standard processes for biomarker analyses.

Ausbildung

PhD or MSc in Biostatistics, Statistics or Mathematics

Tools

PyTorch

TensorFlow

Keras

R (Bioconductor)

Bioconductor

Jobbeschreibung

Syneos Health, Inc. is seeking a Principal Biostatistician - Biomarker to lead biomarker statistics across European studies. The role focuses on RNA/genomics data, AI/ML integration, and advanced analytics with production-level code in Python/R.

Strong collaboration with cross-functional teams is required and independence is essential. You will contribute to Biomarker Evaluation Plans, reports, and interpretation of statistical deliverables within a pharma context, spanning diverse therapeutic